NCT07048470View on ClinicalTrials.gov

Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Systemic Lupus Erythematosus
Interventions
DIETARY_SUPPLEMENT

Synbiotic

The patients received synbiotics (containing Lactobacillus helveticus R0052 60%, Bifidobacterium infantis R0033 20%, Bifidobacterium bifidum R0071 20% and frukto-oligosaccharide 80 mg) supplementation

DIETARY_SUPPLEMENT

Placebo

Patients received placebo capsules

Trial Locations (1)

30126

Mohammad Hoesin General Hospital, Palembang

All Listed Sponsors
lead

Universitas Sriwijaya

OTHER

NCT07048470 - Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients | Biotech Hunter | Biotech Hunter